uPAR Inhibitors

Common uPAR Inhibitors include, but are not limited to Amiloride CAS 2609-46-3, Dansylcadaverine CAS 10121-91-2, Genistein CAS 446-72-0, Curcumin CAS 458-37-7 and Amiloride CAS 2609-46-3.

uPAR inhibitors belong to a specific chemical class of compounds designed to target and inhibit the activity of Urokinase-Type Plasminogen Activator Receptor (uPAR). uPAR is a cell surface receptor that plays a crucial role in the regulation of plasminogen activation and subsequent fibrinolysis, extracellular matrix remodeling, and cell migration. It is involved in a wide range of physiological and pathological processes, including tissue repair, inflammation, and cancer metastasis.

uPAR inhibitors work by specifically targeting the uPAR receptor, interfering with its interactions with urokinase-type plasminogen activator (uPA) and other binding partners. By doing so, these inhibitors may modulate the activation of plasminogen and the downstream proteolytic activities, impacting processes like tissue remodeling and cell motility. Research into uPAR inhibitors is ongoing to unravel their precise mechanisms of action and explore their implications in understanding proteolytic cascades and cellular responses. The study of uPAR inhibitors contributes to a deeper understanding of the intricate mechanisms governing extracellular matrix dynamics and cellular behavior.